Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
about
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesA review of the efficacy and safety of nanoparticle-based oral insulin delivery systemsRecent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesCalcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammationCharacterization of biologically active insulin-loaded alginate microparticles prepared by spray drying.Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice.Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach.Challenges and advances in nanoparticle-based oral insulin delivery.An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery.Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment.Nanoparticles Prepared From N,N-Dimethyl-N-Octyl Chitosan as the Novel Approach for Oral Delivery of Insulin: Preparation, Statistical Optimization and In-vitro Characterization.Prerequisite Characteristics of Nanocarriers Favoring Oral Insulin Delivery: Nanogels as an OpportunityImpact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorptionChitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin
P2860
Q26779447-41402BC3-B748-4AAC-B915-C91C6EDB0DD3Q26999867-4D447432-3294-4798-A10C-83F133E6F550Q27028129-BA9170E4-1D23-4152-BDB4-262EF0ACBF01Q28538368-368F50EE-D006-4B14-965C-CDFF8B1C3E6CQ30413988-A6233C84-8C6F-49B5-A8AA-E201C55A1546Q34046035-F8AC7623-61B5-42C4-93EF-4AFBDB38CAE1Q35577258-B24ECBAB-444C-4A27-87FB-FF0BCF5B60D7Q37380059-7BADA665-5CE6-43A8-87E8-8A4257935962Q37632407-7AB5ED00-E9A0-4BE9-9715-7B7163E78F35Q38681052-5EBC211C-0F6B-4BF1-8B7E-3C42B92DA20DQ39212810-6A73EFDC-5140-435F-8B24-B64DEA79C37BQ39383421-EDBF0251-F172-4C69-8FC5-A8BA1EB3C29BQ41557477-578CA513-105C-4945-BED6-CB087B7CE198Q54953729-CCFFC151-CD9F-4567-BB64-AD54D816EBE3Q57348419-7761EE34-A2BE-4986-A018-47262CA930A3Q57570696-B4C41F19-4A5C-464E-B95C-CDA02E9485E9Q57570886-DB1B7D7A-8AF0-4F26-9187-E67A359FD520
P2860
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@en
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@nl
type
label
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@en
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@nl
prefLabel
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@en
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
@nl
P50
P921
P356
P1476
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response
@en
P2093
Christiane Damgé
Ronald J Neufeld
P304
P356
10.1002/JPS.21347
P407
P577
2008-12-01T00:00:00Z